【英文論文】

Sha'ari HM, Haerian BS, Baum L, Saruwatari J, Tan HJ, Rafia MH, Raymond AA, Kwan P, Ishitsu T, Nakagawa K, Lim KS, Mohamed Z.
ABCC2 rs2273697 and rs3740066 polymorphisms and resistance to antiepileptic drugs in Asia Pacific epilepsy cohorts.
Pharmacogenomics. 2014;15(4):459-66.

Tabata N, Hokimoto S, Akasaka T, Arima Y, Kaikita K, Kumagae N, Morita K, Miyazaki H, Oniki K, Nakagawa K, Matsui K, Ogawa H.
Chronic kidney disease status modifies the association of CYP2C19 polymorphism in predicting clinical outcomes following coronary stent implantation.
Thromb Res. 2014;134(5):939-44.

Hokimoto S, Chitose T, Mizobe M, Akasaka T, Arima Y, Kaikita K, Iwashita S, Morita K, Miyazaki H, Oniki K, Matsui K, Nakagawa K, Ogawa H.
Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery disease.
Eur J Clin Pharmacol. 2014;70(6):667-73.

Mizobe M, Hokimoto S, Akasaka T, Arima Y, Kaikita K, Morita K, Miyazaki H, Oniki K, Nakagawa K, Ogawa H.
Impact of CYP2C19 polymorphism on clinical outcome following coronary stenting is more important in non-diabetic than diabetic patients.
Thromb Res. 2014;134(1):72-7.

Hokimoto S, Mizobe M, Akasaka T, Kaikita K, Nakagawa K, Ogawa H.
Impact of CYP2C19 Polymorphism and Proton Pump Inhibitors on Platelet Reactivity to Clopidogrel and Clinical Outcomes Following Stent Implantation.
Thromb Res. 2014;133(4):599-605.

Hirata K, Saruwatari J, Enoki Y, Iwata K, Urata Y, Aizawa K, Ueda K, Shirouzono T, Imamura M, Moriuchi H, Ishima Y, Kadowaki D, Watanabe H, Hirata S, Maruyama T, Fukunaga E.
Possible false-negative results on therapeutic drug monitoring of phenytoin using a particle enhanced turbidimetric inhibition immunoassay in a patient with a high level of IgM.
Ther Drug Monit. 2014 ;36(5):553-5.

Saruwatari J, Uchiyashiki Y, Kajiwara A, Noai M, Tanamachi Y, Soraoka H, Deguchi M, Oniki K, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagawa K.
A Possible Association of Sex Hormone-Binding Globulin with Weight Gain in the Valproic Acid-Treated Female Patients with Epilepsy.
Int J Clin Pharmacol Ther 2014;3(1):1-5.

Saruwatari J, Takashima A, Yoshida K, Soraoka H, Tong-Bin Ding, Uchiyashiki Y, Tsuda Y, Imamura M, Oniki K, Miyata K, Nakagawa K.
Effects of seijo-bofu-to, a traditional Japanese herbal medicine containing furanocoumarin derivatives, on the drug-metabolizing enzyme activities in healthy male volunteers.
Basic Clin Pharmacol Toxicol. 2014;115(4):360-5.

Saruwatari J, Nakashima H, Tsuchimine S, Nishimura M, Ogusu N, Yasui-Furukori N.
Possible impact of the cytochrome P450 2D6 polymorphism, CYP2D6*10, on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders.
Pharmgenomics Pers Med. 2014;7(1):121-7.

Ogusu N, Saruwatari J, Nakashima H, Noai M, Nishimura M, Deguchi M, Oniki K, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagawa K.
Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis.
PLoS One. 2014;9(11):e111066.

Saruwatari J, Ogusu N, Shimomasuda M, Nakashima H, Seo T, Tanikawa K, Tsuda Y, Nishimura M, Nagata R, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagawa K.
Effects of CYP2C19 and P450 oxidoreductase polymorphisms on the population pharmacokinetics of clobazam and N-desmethylclobazam in Japanese patients with epilepsy.
Ther Drug Monit.2014;36:302-309.

Tsuda Y, Saruwatari J, Yasui-Furukori N.
Meta-analysis: The effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine.
BMJ Open. 2014;4(3):e004216.

Kajiwara A, Saruwatari J, Kita A, Oniki K, Yamamura M, Murase M, Koda H, Hirota S, Ishizuka T, Nakagawa K.
Younger females are at greater risk of vasodilation-related adverse symptoms caused by dihydropyridine calcium channel blockers: results of a study of 11,918 Japanese patients.
Clin Drug Investig.2014;34:431-435.

Kajiwara A, Sakata M, Kita A, Morita K, Oniki K, Saruwatari J, Yoshida A, Jinnouchi H, Nakagawa K.
Clinical features associated with a rapid decline in renal function among Japanese patients with type 2 diabetes mellitus: Microscopic hematuria coexisting with diabetic retinopathy.
World Biomed Front. Diabetes and Obesity. 2014 Jan-Feb.

Kajiwara A, Kita A, Saruwatari J, Morita K, Oniki K, Yamamura M, Murase M, Koda H, Hirota S, Ishizuka T, Nakagawa K.
Absence of gargling affects topical adverse symptoms caused by inhaled corticosteroids in females.
J Asthma. 2014;51(2):221-4.

Kajiwara A, Miyagawa H, Saruwatari J, Kita A, Sakata M, Kawata Y, Oniki K, Jinnouchi H, Nakagawa K.
Gender differences in the incidence and progression of diabetic retinopathy among Japanese patients with type 2 diabetes mellitus: A clinic-based retrospective longitudinal study.
Diabetes Res Clin Pract. 2014 ;103(3):e7-10.

Morita K, Miyazaki H, Saruwatari J, Oniki K, Kumagae N, Tanaka T, Kajiwara A, Otake K, Ogata Y, Arima Y, Hokimoto S, Ogawa H, Nakagawa K.
Combined effects of current-smoking and the aldehyde dehydrogenase 2*2 allele on the risk of myocardial infarction in Japanese patients.
Toxicol Lett. 2014;232(1):221-5.

Morita K, Oniki K, Miyazaki H, Saruwatari J, Ogata Y, Mizobe M, Yamamuro M, Hokimoto S, Ogawa H, Nakagawa K.
Aldehyde dehydrogenase 2 as a potential protective factor for renal insufficiency in Japanese subjects with heart failure: a pilot study.
J Hum Hypertens. 2014;28(4):279-281.

Saruwatari J, Yoshida S, Tsuda Y, Okada Y, Ogusu N, Yoshida K, Oniki K, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagawa K.
Pregnane X receptor and hepatocyte nuclear factor 4α polymorphisms are cooperatively associated with carbamazepine autoinduction.
Pharmacogenet Genomics. 2014;24(3):162-71.

【和文総説】

岩佐博人、猿渡淳二．
てんかん薬物療法実践のポイント －臨床効果の評価を踏まえた視点から－．
薬局.2014;65:94-102.